Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor

被引：0
|
作者：
Sanne Hage La Cour
Kiki Juhler
Lisette J. A. Kogelman
Jes Olesen
Dan Arne Klærke
David Møbjerg Kristensen
Inger Jansen-Olesen
机构：
[1] University of Copenhagen,Danish Headache Center, Department of Neurology, Rigshospitalet
[2] University of Copenhagen,Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences
[3] Inserm (Institut national de la santé et de la recherche médicale),Department of Biology
[4] Irset - Inserm UMR 1085,undefined
[5] University of Copenhagen,undefined
来源：
The Journal of Headache and Pain | 2022年 / 23卷
关键词：
Migraine; CGRP; oocytes ; Amylin; Amylin receptor; RAMP1; CLR; CTR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor
    La Cour, Sanne Hage
    Juhler, Kiki
    Kogelman, Lisette J. A.
    Olesen, Jes
    Klaerke, Dan Arne
    Kristensen, David Mobjerg
    Jansen-Olesen, Inger
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [2] Characterization of erenumab and rimegepant affinity towards calcitonin gene-related peptide and amylin-1 receptors: Possible explanation for constipation by erenumab
    La Cour, S. H.
    Juhler, K.
    Kogelman, L. J. A.
    Olesen, J.
    Klaerke, D.
    Kristensen, D. M.
    Jansen-Olesen, I.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 37 - 38
  • [3] Characterization of erenumab and rimegepant affinity towards calcitonin gene-related peptide and amylin-1 receptors: Possible explanation for constipation by erenumab
    La Cour, S. H.
    Juhler, K.
    Kogelman, L. J. A.
    Olesen, J.
    Klaerke, D.
    Kristensen, D. M.
    Jansen-Olesen, I.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 56 - 56
  • [4] Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
    Lipton, Richard B.
    Croop, Robert
    Stock, Elyse G.
    Stock, David A.
    Morris, Beth A.
    Frost, Marianne
    Dubowchik, Gene M.
    Conway, Charles M.
    Coric, Vladimir
    Goadsby, Peter J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (02): : 142 - 149
  • [5] Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: A peptide superfamily
    Wimalawansa, SJ
    CRITICAL REVIEWS IN NEUROBIOLOGY, 1997, 11 (2-3): : 167 - 239
  • [6] Rimegepant Calcitonin gene-related peptide (CGRP) receptor antagonist Treatment of migraine
    Lionetto, L.
    Capi, M.
    Curto, M.
    Cipolla, F.
    Guglielmetti, M.
    Martelletti, P.
    DRUGS OF THE FUTURE, 2019, 44 (08) : 635 - 642
  • [7] Amylin, calcitonin gene-related peptide, and adrenomedullin: Effects on thiazide receptor and calcium
    Blakely, P
    Vaughn, DA
    Fanestil, DD
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 272 (03) : F410 - F415
  • [8] Pharmacology of receptors for calcitonin gene-related peptide and amylin
    Poyner, D
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (12) : 424 - 428
  • [9] Calcitonin gene-related peptide receptor antagonists for migraine
    Fischer, Michael J. M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (07) : 815 - 823
  • [10] Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development
    Cornish, J
    Callon, KE
    Bava, U
    Kamona, SA
    Cooper, GJS
    Reid, IR
    BONE, 2001, 29 (02) : 162 - 168
12345